Pacific Biosciences of California (NASDAQ:PACB) Trading Outlook
PAC BIOSCN OF CL closed down -0.770 at 7.300. Volume was 146% above average (neutral) and Bollinger Bands were 342% wider than normal.
Open High Low Close Volume___
8.030 8.270 7.200 7.300 3,120,837
Technical Outlook
Short Term: Overbought
Intermediate Term: Bullish
Long Term: Bullish
The current market condition for PAC BIOSCN OF CL is:
Very Bullish
The close is currently Above it’s 200 period moving average.
The close is currently Above it’s 90 period moving average.
The close is currently Above it’s 30 period moving average.
Moving Averages: 10-period 50-period 200-period
Close: 6.22 4.98 5.92
Volatility: 271 149 93
Volume: 6,980,333 1,827,672 957,365
Short-term traders should pay closer attention to buy/sell arrows while intermediate/long-term traders should place greater emphasis on the Bullish or Bearish trend reflected in the lower ribbon.
Summary
PAC BIOSCN OF CL is currently 23.3% above its 200-period moving average and is in an upward trend. Volatility is extremely high when compared to the average volatility over the last 10 periods. There is a good possibility that volatility will decrease and prices will stabilize in the near term. Our volume indicators reflect very strong flows of volume into PACB.O (bullish). Our trend forecasting oscillators are currently bullish on PACB.O and have had this outlook for the last 6 periods.
Momentum Indicators
Momentum is a general term used to describe the speed at which prices move over a given time period. Generally, changes in momentum tend to lead to changes in prices. This expert shows the current values of four popular momentum indicators.
Stochastic Oscillator
One method of interpreting the Stochastic Oscillator is looking for overbought areas (above 80) and oversold areas (below 20). The Stochastic Oscillator is 73.6397. This is not an overbought or oversold reading. The last signal was a sell 0 period(s) ago.
Relative Strength Index (RSI)
The RSI shows overbought (above 70) and oversold (below 30) areas. The current value of the RSI is 67.77. This is not a topping or bottoming area. However, the RSI just crossed below 70 from a topping formation. This is a bearish sign. A buy or sell signal is generated when the RSI moves out of an overbought/oversold area. The last signal was a sell 0 period(s) ago.
Commodity Channel Index (CCI)
The CCI shows overbought (above 100) and oversold (below -100) areas. The current value of the CCI is 97. This is not a topping or bottoming area. The last signal was a sell 0 period(s) ago.
MACD
The Moving Average Convergence/Divergence indicator (MACD) gives signals when it crosses its 9 period signal line. The last signal was a buy 7 period(s) ago.
Pacific Biosciences of California Inc., incorporated in July 14, 2000, designs, develops and manufactures the PacBio RS II Sequencing System to help scientists resolve genetically complex problems. Based on the Company’s Single Molecule, Real-Time (SMRT) technology, its products enable de novo genome assembly to finish genomes in order to more fully identify, annotate and decipher genomic structures; full-length transcript analysis to improve annotations in reference genomes, characterize alternatively spliced isoforms and find genes; targeted sequencing to more comprehensively characterize genetic variations; and DNA (deoxyribonucleic acid) base modification identification to help characterize epigenetic regulation and DNA damage. SMRT enables single molecule, real-time detection of biological processes. Based on its SMRT technology, the Company introduced the PacBio RS II System to address many of the limitations.
SMRT Technology
The Company’s SMRT technology enables the observation of DNA synthesis as it occurs in real-time by harnessing the natural process of DNA replication, which is actuated by the DNA polymerase. The DNA polymerase attaches itself to a strand of DNA to be replicated, examines the individual base at the point it is attached, and then determines which of four building blocks or nucleotides is required to complement that individual base.
SMRT Cell
The Company’s DNA sequencing is performed on SMRT Cells each having an array of approximately 150,000 zero-mode waveguides (ZMW). ZMW has the ability to detect a single incorporation event against the background of fluorescently labeled nucleotides at biologically relevant concentrations.
Phospholinked Nucleotides
The Company’s phospholinked nucleotides have a fluorescent dye attached to the phosphate chain of the nucleotide rather than to the base. As a natural step in the synthesis process, the phosphate chain is cleaved when the nucleotide is incorporated into the DNA strand. Thus, upon incorporation of a phospholinked nucleotide, the DNA polymerase naturally frees the dye molecule from the nucleotide when it cleaves the phosphate chain.
PacBio RS II
The PacBio RS II is an instrument that conducts, monitors and analyzes single molecule biochemical reactions in real-time. The PacBio RS II uses a high numerical aperture objective lens and four single-photon sensitive cameras to collect the light pulses emitted by fluorescent reagents allowing the observation of biological processes. An optimized set of algorithms is used to translate the information that is captured by the optics system. The automated liquid handling system performs reagent mixing and prepares SMRT Cells.
The Company competes with Illumina, Inc. and Thermo Fisher Scientific Inc.
The post Pacific Biosciences of California (NASDAQ:PACB) Trading Outlook appeared first on Live Trading News.